Through Usp9x-mediated, site-specific deubiquitination, Ets-1 proteasomal destruction is inhibited, resulting in Ets-1 accumulation and increased melanoma tumorigenicity, which could be blocked by inhibition of Usp9x activity or knockdown of Ets-1. Here, ETS1 is linked to melanoma.